Peptide Sciences semaglutide is a next-generation GLP-1 (glucagon-like peptide-1) analog developed for research applications. This long-acting compound builds upon the structure of liraglutide with enhanced pharmacological properties.
The molecular structure features an extended aliphatic chain and increased hydrophobicity, combined with PEG modification that significantly improves hydrophilicity. This unique modification provides multiple research advantages including tight albumin binding, protection against enzymatic hydrolysis, reduced renal clearance, and extended biological half-life.
Our Peptide Sciences semaglutide is supplied as a white lyophilized powder in sterile vials, available in various concentrations to meet different research requirements. The product undergoes rigorous quality control testing to ensure batch-to-batch consistency.
Important Note: This product is intended for research purposes only. Not for human consumption or diagnostic use.